ライフサイエンスコーパス: left ventricular mass

1 ied as scar percentage (infarcted mass/total left ventricular mass).

2 h incident cardiovascular disease and higher left ventricular mass.

3 % (interquartile range: 1.3% to 4.1%) of the left ventricular mass.

4 fat compartment is strongly correlated with left ventricular mass.

5 s of wave reflection are not associated with left ventricular mass.

6 organ damage as measured by albuminuria and left ventricular mass.

7 abetes, and had larger left atria and higher left ventricular mass.

8 graphic PR interval, atrial fibrillation and left ventricular mass.

9 ardiac magnetic resonance imaging-determined left ventricular mass.

10 mber dilation and a compensatory increase in left ventricular mass.

11 bjects (13%; P<0.0001) with no difference in left ventricular mass.

12 as 39% (SD 12) and scar occupied 24% (10) of left ventricular mass.

13 age, sex, hypertension, body mass index, and left ventricular mass.

14 ntricular size and a substantial increase in left ventricular mass.

15 tment to determine maximal oxygen uptake and left ventricular mass.

16 septum (62%), despite a greater increase in left ventricular mass.

17 (ACE-I) results in substantial reduction in left ventricular mass.

18 is link did not explain the association with left ventricular mass.

19 t, and attenuated a pathological increase in left ventricular mass.

20 secondary objective was to assess changes in left ventricular mass.

21 f body composition and fat distribution, and left ventricular mass.

22 n=4 per group, p<0.02) resulting in greater left-ventricular mass (1.24 [0.29] vs 1.57 [0.27] g) and

23 ure (diastolic dimension [1.5%, P=0.008] and left ventricular mass [1.6%, P=0.008]), resting stroke v

24 lumes (96 versus 40 mL), and greater indexed left ventricular mass (101 versus 85 g/m(2); P<0.01 for

25 A significant reduction in left ventricular mass (118+/-24 g vs. 101+/-18 g) and ca

26 tone resulted in significant improvements in left ventricular mass (-14 +/- 13 g vs. +3 +/- 11 g, p <

27 t failure were more likely to have increased left ventricular mass (17.0 percent vs. 26.9 percent), l

28 ll thickness (0.83 and 0.78 versus 0.72 cm), left ventricular mass (182 and 161 versus 137 g), and re

29 L-NAME induced hypertrophy (weight-indexed left-ventricular mass 2.2+/-0.3 versus 4.1+/-0.4 mug/g,

30 r (-0.75 mm [95% CI, -0.95 to -0.56]), lower left ventricular mass (-3.9 g [95% CI, -5.5 to -2.3]), a

31 short-axis cine images were used to quantify left ventricular mass, 3-dimensional geometric variation

32 (7.1+/-1.2 versus 5.1+/-1.1 cm; P<0.001) and left ventricular mass (320+/-113 versus 194+/-79 g; P<0.

33 diameter (0.34 mm [95% CI, -0.09 to 0.78]), left ventricular mass (4.6 g [95% CI, 1.1-8.1]), and sys

34 54.1 years; p = 0.002) and had lower indexed left ventricular mass (5.1 g/m(2) reduction; padjusted =

35 Individuals born preterm had increased left ventricular mass (66.5+/-10.9 versus 55.4+/-11.4 g/

36 g alcohol intake was associated with greater left ventricular mass (8.2+/-3.8 g per consumption categ

37 entricular posterior wall, 11+/-4 [7-21] mm; left ventricular mass, 86+/-41 [46-195] g/m(2)) was prog

38 s associated with an estimated 2.4-g greater left ventricular mass (95% confidence interval, 0.4-4.5

39 l body weight had fallen by 3% (P<0.05), but left ventricular mass, adjusted for changes in body surf

40 tricular weight, right ventricle weight, and left ventricular mass after 4 months of VD deficiency.

41 operated mice showed significantly increased left ventricular mass after 7 days.

42 influence of these factors on changes in the left ventricular mass after renal transplantation.

43 cid and renal dysfunction, on changes in the left ventricular mass after renal transplantation.

44 videnced by greater left atrial diameter and left ventricular mass although diastolic dysfunction was

45 ngiotensin receptor blockers (ARBs) improves left ventricular mass and arterial stiffness in early-st

46 Exercise training increased left ventricular mass and blood volume by approximately

47 There was no significant correlation between left ventricular mass and BP either at HBPM or ABPM.

48 loss of diurnal BP variation; (d) increased left ventricular mass and cavity dimensions; (e) decreas

49 Left ventricular mass and CK metabolite levels in LVH we

50 spontaneously hypertensive rats, it reduced left ventricular mass and collagen content, reduced prot

51 function at submaximal and maximal exercise, left ventricular mass and compliance, and blood volume c

52 ary composite outcomes of death or change in left ventricular mass and death or change in self-report

53 extracellular volume (r=0.72; P<0.01), with left ventricular mass and E' velocity (r=0.45, -0.60, re

54 To examine left ventricular mass and evaluate factors associated wi

55 Contrast-to-noise ratios (CNRs) and left ventricular mass and function measurements with thi

56 Both SUR1-tg and Kir6.2 KO mice had normal left ventricular mass and function under unstressed cond

57 worse CAD, lower ejection fraction, greater left ventricular mass and higher C-reactive protein valu

58 over time was associated with an increase in left ventricular mass and higher mortality.

59 tic root diameter, left atrial diameter, and left ventricular mass and higher systolic blood pressure

60 dy demonstrates that allopurinol can regress left ventricular mass and improve endothelial function a

61 The use of spironolactone reduces left ventricular mass and improves arterial stiffness in

62 Left ventricular mass and LA size were independently ass

63 atients with diabetes mellitus had a greater left ventricular mass and left atrial area than patients

64 ty, body mass index (BMI), serum creatinine, left ventricular mass and left ventricular ejection frac

65 over time was associated with a decrease in left ventricular mass and lower mortality, whereas a dec

66 enabled surprising quantitative estimates of left ventricular mass and mitral annulus e' velocity (me

67 Quantitative ECG measures of left ventricular mass and repolarization predict outcome

68 Indexed left ventricular mass and right ventricular mass (left v

69 ationship was evident between LGE by percent left ventricular mass and SCD event risk in HCM patients

70 of patients from both groups, we reassessed left ventricular mass and self-reported physical health

71 tients have a detectable, small reduction in left ventricular mass and storage.

72 C-EV injection also resulted in reduction in left ventricular mass and superior perfusion in the infa

73 le factors may contribute to lower levels of left ventricular mass and volume.

74 resonance images for assessment of right and left ventricular mass and volumes were obtained at basel

75 owed that treatment with losartan normalized left ventricular mass and wall thickness.

76 mal blood pressure, while maintaining normal left ventricular mass and wall thickness.

77 here were no significant differences between left ventricular masses and systemic pressures, and ther

78 e heart, such as increased left atrial size, left ventricular mass, and alterations in transmitral ve

79 We measured body fat distribution, left ventricular mass, and blood pressure at the age of

80 Age, left ventricular mass, and body surface area were the ma

81 usted for age, race/ethnicity, hypertension, left ventricular mass, and end-diastolic volume.

82 (aortic root diameter, left atrial diameter, left ventricular mass, and fractional shortening), carot

83 assical Fabry disease had lower eGFR, higher left ventricular mass, and higher plasma globotriaosylsp

84 measured global longitudinal strain, indexed left ventricular mass, and indexed left atrial volume.

85 adjusted for baseline left atrial dimension, left ventricular mass, and left ventricular fractional s

86 rt failure as measured by ejection fraction, left ventricular mass, and lung congestion.

87 Measures of left atrial size, left ventricular mass, and peak A velocity at baseline w

88 ischemic region was 40.1+/-3.1% of the total left ventricular mass, and the infarct size was 47.5+/-3

89 creased viral titers in the heart, increased left ventricular mass, and thickening of the left ventri

90 adjustment for age, gender, body mass index, left ventricular mass, and traditional risk factors.

91 apeutic efficacy, such as ejection fraction, left ventricular mass, and ventricular volume, can be de

92 -1.5); 1.30 (1.15-1.48) per 1 SD increase in left ventricular mass; and 1.15 (1.02-1.30) per 1 SD inc

93 brachial pulse and systolic blood pressure, left ventricular mass, aortic wall thickness and mean ao

94 Heart weight and left ventricular mass are elevated, and histology reveal

95 ess and system inflammation and reduction of left ventricular mass are less robust.

96 The primary endpoint was change in left ventricular mass as assessed by cardiac magnetic re

97 Echocardiography showed increases in left ventricular mass as well as end-diastolic and end-s

98 re paravalvular leak at 30 days, and greater left ventricular mass at 30 days.

99 less valve, there were similar reductions in left ventricular mass at 6 months with both stented and

100 0.001) and a doubling (or more) of risk with left ventricular mass at the mean value or lower (P for

101 Hypoenhanced areas (as a percentage of left ventricular mass) at first-pass multidetector CT (1

102 flow response was associated with increased left ventricular mass (B=-12.7 g.m(-2.7) per L.min(-1).m

103 in FVC from peak was associated with larger left ventricular mass (beta = 6.05 g per SD of FVC decli

104 d no significant difference in the change in left ventricular mass between the placebo group and the

105 Pairs were matched for age, gender, indexed left ventricular mass, body mass index and low-density l

106 ventricular mass and right ventricular mass (left ventricular mass/body surface area, 96+/-13 and 62+

107 lograft hypertrophy, we measured the gain in left ventricular mass by 2D echocardiography in heart tr

108 tid intima-media thickness, ankle-arm index, left ventricular mass by ECG, and a major ECG abnormalit

109 The MESA measured left ventricular mass by MRI, coronary calcium by comput

110 ly acquired and later analyzed for right and left ventricular mass by radial summation technique from

111 roalbuminuria was positively associated with left ventricular mass (by 14.8 g), leading to a signific

112 (bioimpedance spectroscopy), 24-hour BP, and left ventricular mass (cardiac magnetic resonance imagin

113 Left ventricular mass (cardiac magnetic resonance) and a

114 Whether the differences in left-ventricular mass changes are related to endogenous

115 and known genetic variants predict increased left ventricular mass, circulating levels of NT-proBNP,

116 ersus 20 of 64 [31%]; P<0.001) and change in left ventricular mass correlated with intraseason change

117 Consequently, an increase in left ventricular mass corresponding to exaggerated wall

118 LV left ventricular wall thinning with LV left ventricular mass decrease occurred at follow-up (S0

119 s the amount of microvascular obstruction (% left ventricular mass) demonstrated by contrast-enhanced

120 abnormal results on perfusion scans (<10% of left ventricular mass) during stress (n = 136), a preser

121 ar filtration rate (isotopic clearance), and left ventricular mass (echocardiography) assessment were

122 c use, estimated glomerular filtration rate, left ventricular mass, ejection fraction, and wall motio

123 ificantly lower adjusted mean values for the left ventricular mass, end diastolic volume, and stroke

124 It ranged from approximately 8 g shift in left ventricular mass for 10p13 locus heterozygosity for

125 gy and developed normal values for right and left ventricular mass from 15 weeks' gestation to term.

126 o 114 424 +/- 9564 nuclei/mm3, P < 0.01) and left ventricular mass (from 2.5 +/- 0.1 to 2.8 +/- 0.1 g

127 ts born preterm have distinct differences in left ventricular mass, function, and geometry.

128 gender, cardiovascular (CV) disease, EF, and left ventricular mass, grade II DD was associated with a

129 CMR-LVH was defined as left ventricular mass >/=95th percentile of the MESA pop

130 udinal strain (>15% improvement) and indexed left ventricular mass (>20% decrease) at 1 year occurred

131 rp step-up was observed for scar size >5% of left ventricular mass (hazard ratio [HR]: 5.2; 95% confi

132 uretic peptide, ejection fraction, E/E', and left ventricular mass (hazard ratio: 1.164; 95% confiden

133 y arterial hypertension (PAH), and increased left ventricular mass (ILVM) in antiretroviral therapy (

134 Individuals born preterm have increased left ventricular mass in adult life.

135 Gal-3 was associated with increased left ventricular mass in age-adjusted and sex-adjusted a

136 Increasing left ventricular mass in athlete's heart occurs because

137 acteristics demonstrate the association with left ventricular mass in healthy non-obese population.

138 ssion of carotid IMT and greater decrease in left ventricular mass in individuals with type 2 diabete

139 skin sodium content to be closely linked to left ventricular mass in patients with CKD.

140 has been found to accelerate the increase in left ventricular mass in patients with hypertension.

141 consortium) and rs198389 and rs3733402 with left ventricular mass in whites (EchoGEN consortium).

142 od pressure, a high-salt diet also increases left ventricular mass, incidence of strokes, stiffness o

143 r: a difference which becomes more marked as left ventricular mass increases.

144 Whereas left-ventricular mass increases with age in apparently h

145 P < .001); and there was greater decrease in left ventricular mass index (-2.4 g/m(2.7) vs -1.2 g/m(2

146 participants (H, n = 9) demonstrated higher left ventricular mass index (115 +/- 20 vs. 90 +/- 16 g/

147 were independently associated with increased left ventricular mass index (5% increase per 1-SD increa

148 ontrols increased maximum wall thickness and left ventricular mass index (9.8+/-2.7 versus 10.2+/-2.6

149 /-5.9 versus 14.4+/-5.7 mm; P=0.028), stable left ventricular mass index (93+/-42 versus 92+/-40 g/m(

150 rcise-induced wall motion abnormalities, and left ventricular mass index (beta=-0.41 [95% confidence

151 ion fraction, stroke volume index, E/E', and left ventricular mass index (hazard ratio, 4.1; 95% conf

152 fraction (HR, 0.42; 95% CI, 0.20-0.89), and left ventricular mass index (HR, 1.19; 95% CI, 1.04-1.36

153 lization (OR, 9.36; 95% CI, 2.55-34.38), and left ventricular mass index (in g/m(2)) (OR, 1.02; 95% C

154 standard (135-140/85-90 mmHg) BP control on left ventricular mass index (LVMI) and kidney function i

155 he relationship between hematocrit (Hct) and left ventricular mass index (LVMI) and LV hypertrophy (L

156 d larger left atrial (LA) volumes and higher left ventricular mass index (LVMI) and LV mass/LV volume

157 ve a higher arterial afterload and increased left ventricular mass index (LVMI) compared with control

158 Left ventricular mass index (LVMI) correlated to the sam

159 and ABP and evaluate their associations with left ventricular mass index (LVMI) in untreated persons.

160 The primary outcome was change in left ventricular mass index (LVMI) measured by transthor

161 led trial evaluated the effect of EVL on the left ventricular mass index (LVMi) of 30 nondiabetic RTR

162 Greater early left ventricular mass index (LVMi) regression is associa

163 and obese hypertensive patients had greater left ventricular mass index (LVMI) values, but on multiv

164 ssure (SBP), heart rate (HR), pathology, and left ventricular mass index (LVMI) were measured.

165 We measured left ventricular mass index (LVMI) with cardiac magnetic

166 Ventricular dysfunction was defined using left ventricular mass index (LVMI), LV global longitudin

167 line and 12-mo measures of echocardiographic left ventricular mass index (LVMI), serum C-reactive pro

168 and after 12 months there was a reduction in left ventricular mass index (p < 0.03).

169 id not significantly differ in the change in left ventricular mass index (P = 0.37), left ventricular

170 correlation with O2max (r=-0.53, P=0.003 and left ventricular mass index (r=-0.44, P=0.02).

171 rams and computed tomography scans to assess left ventricular mass index and coronary artery calcific

172 late human aging: age-dependent increases in left ventricular mass index and left atrial dimension, w

173 Left ventricular mass index and left atrial volume index

174 FGF-23 is independently associated with left ventricular mass index and left ventricular hypertr

175 Prespecified end points included left ventricular mass index and, in a subpopulation of p

176 The main outcome was left ventricular mass index by cardiac magnetic resonanc

177 Spironolactone induced reverse remodeling (left ventricular mass index declined; difference, -6 g/m

178 During the study, LVH prevalence and mean left ventricular mass index did not change significantly

179 At 48 weeks, the change in left ventricular mass index did not differ between treat

180 The mean change in left ventricular mass index from randomization was simil

181 The left ventricular mass index had good discrimination for

182 Left ventricular mass index in DMTU-treated CKD was less

183 Predictors of left ventricular mass index included systolic BP, anemia

184 The median left ventricular mass index measured with echocardiograp

185 Moreover, this increase in left ventricular mass index occurs in children who have

186 on fraction of 65.5%+/-12.0% and a mean+/-SD left ventricular mass index of 66.6+/-22.3 g/m(2.7) Duri

187 week therapy with paricalcitol did not alter left ventricular mass index or improve certain measures

188 tricted to the CKD subjects (11% increase in left ventricular mass index per 1-SD increase in log FGF

189 y disease is typically assessed by measuring left ventricular mass index using echocardiography or ca

190 sing to 54.7% at 3 years (p < 0.0001), while left ventricular mass index was 136.4 g/m(2), decreasing

191 g the subset of participants with ALVSD, the left ventricular mass index was particularly informative

192 In bivariate analyses, age, left ventricular mass index, and DD grade were positivel

193 re, cholesterol, smoking, ejection fraction, left ventricular mass index, and diabetes mellitus-the e

194 nemia, sodium intake, income, fat-free mass, left ventricular mass index, and ejection fraction.

195 e in serum uric acid during follow-up, final left ventricular mass index, and final glomerular filtra

196 ted with greater disease severity, a greater left ventricular mass index, and higher hospitalization

197 ng 20 or 40mg/kg/day showed a decline in the left ventricular mass index, compared to an increase in

198 ncentration of 135 mmol/L did not change the left ventricular mass index, despite significant reducti

199 ion fraction, but individual adjustments for left ventricular mass index, left atrial area, and inter

200 ressure, left ventricular ejection fraction, left ventricular mass index, left ventricular dimension,

201 Secondary end points were changes in left ventricular mass index, left ventricular ejection f

202 636307) in RGS3 showed pleiotropic effect on left ventricular mass index, left ventricular volume ind

203 lysis showed neutrophils, total cholesterol, left ventricular mass index, mitral inflow E/A ratio, an

204 ) had more severe aortic stenosis, increased left ventricular mass index, more myocardial injury (hig

205 Cardiovascular magnetic resonance (left ventricular mass index, T1, T2, global longitudinal

206 medication use, glomerular filtration rate, left ventricular mass index, wall motion abnormalities,

207 model was used to assess the effect of BP on left ventricular mass index, which was measured at three

208 nt and significant determinants of the final left ventricular mass index.

209 improved, with no evidence of an increase in left ventricular mass index.

210 volume but also with significantly increased left ventricular mass index.

211 had reduced kidney cystic weight and reduced left ventricular mass index.

212 agreement among the ECG criteria against the left ventricular mass index.

213 Echocardiography was used to estimate the left ventricular mass index.

214 The left-ventricular-mass index decreased more in the low-bl

215 The left-ventricular-mass index decreased significantly from

216 the estimated GFR, a greater decline in the left-ventricular-mass index, and greater reduction in ur

217 Left ventricular mass indexed according to height at the

218 er, in vivo MRI showed only a 3% increase in left ventricular mass indexed for body weight in mice wi

219 ventricular systolic dysfunction, as well as left ventricular mass, internal dimensions, and wall thi

220 ans, we identified 4 genetic loci related to left ventricular mass, interventricular septal wall thic

221 Left ventricular mass is a risk factor for cardiovascula

222 Left ventricular mass is known to be a powerful independ

223 sus 64%; P=0.99) and the proportion of total left ventricular mass (%late gadolinium enhancement; 10.

224 ng models for examples of cardiac structure (left ventricular mass, left atrial volume, and mitral an

225 nce and severity of coronary artery disease, left ventricular mass, left ventricular ejection fractio

226 ith further adjustment for physical fitness, left ventricular mass, left ventricular ejection fractio

227 Peak filling rate correlated with fat mass, left ventricular mass, leptin, waist-to-hip ratio, and p

228 ents scanned by MRI and SPECT was 14+/-6% of left ventricular mass (%LV) by MRI (range 4%LV to 27%LV)

229 scular obstruction (MO) in the percentage of left ventricular mass (%LV) was assessed by cardiac magn

230 Left ventricular mass (LVM) and cardiac gene expression

231 ren, cardiac abnormalities such as increased left ventricular mass (LVM) and diastolic dysfunction de

232 sonance (CMR)-derived equation for predicted left ventricular mass (LVM) in a cohort of normal indivi

233 ver, information on the relationship between left ventricular mass (LVM) in adults and longitudinal m

234 ascertain if high-dose allopurinol regresses left ventricular mass (LVM) in patients with ischemic he

235 r high-dose allopurinol causes regression of left ventricular mass (LVM) in patients with type 2 diab

236 eatment resulted in a sustained reduction in left ventricular mass (LVM) index after 5 years (from 71

237 Left ventricular mass (LVM) is a highly heritable trait

238 his study was to determine whether increased left ventricular mass (LVM) is a risk factor for the dev

239 An increase in left ventricular mass (LVM) is associated with mortality

240 Left ventricular mass (LVM) is correlated with body comp

241 of ischemic stroke associated with increased left ventricular mass (LVM) is modified by physical acti

242 We assessed left ventricular mass (LVM) regression with transthoraci

243 R and determine the relative contribution of left ventricular mass (LVM) regression, change in aortic

244 f age, serum phosphate, pulse wave velocity, left ventricular mass (LVM), and LVM index (LVMI) increa

245 cardiovascular magnetic resonance to measure left ventricular mass (LVM), and PET to quantify resting

246 Left ventricular mass (LVM), left ventricular (LV) geome

247 t significantly associated with AS gradient, left ventricular mass, mass/volume ratio, or ejection fr

248 dependent of subclinical atherosclerosis and left ventricular mass measures.

249 Left ventricular mass (median [25th, 75th percentiles],

250 ether with preprocedural hospitalization and left ventricular mass, myocardial injury is an independe

251 ller increase in heart-to-body weight ratio, left ventricular mass, myocyte cross-sectional area, hyp

252 ge left ventricular end-diastolic volume and left ventricular mass nor did it improve submaximal exer

253 median changes (95% confidence intervals) in left ventricular mass of -0.84 (-17.1 to 10.0) g and 1.4

254 y end point was microvascular obstruction (% left ventricular mass) on cardiac magnetic resonance ima

255 fibrillation and changes in kidney function, left ventricular mass or BAD.

256 use, lipid levels, progression to diabetes, left ventricular mass or function, and kidney disease.

257 function was not secondary to a reduction in left ventricular mass or through modulation of the after

258 nd systolic blood pressure, and with a lower left ventricular mass (P values<0.05).

259 idase inhibition-positive men showed greater left ventricular mass (P=0.02) and substantially lower r

260 revascularization, 12.6% (7.2% to 22.6%) of left ventricular mass, p = 0.57 (95% confidence interval

261 dian [interquartile range], 7.0 [4.9-7.5]; % left ventricular mass) peaked on day 2 (P<0.001), wherea

262 VEGF treatment preserved left ventricular mass, prevented dilation (T: 1.01+/-0.0

263 crovascular obstruction (MVO) (percentage of left ventricular mass) quantified by cardiac magnetic re

264 rdiovascular magnetic resonance (eg, indexed left ventricular mass R=0.56, P<0.001).

265 T1 values showed a negative correlation with left ventricular mass ( r=-0.79; P<0.0001), maximum wall

266 ongly than total body overhydration did with left ventricular mass (r=0.56, P<0.001 versus r=0.35, P<

267 ve tissue volume fraction and weight-indexed left-ventricular mass (r=0.842 and r=0.737, respectively

268 d pressure, left ventricular wall thickness, left ventricular mass, ratio of heart weight to tibial l

269 lities, including left ventricular dilation, left ventricular mass reduction, and depression of fract

270 Left ventricular mass regression was better associated w

271 e of severe prosthesis-patient mismatch, and left ventricular mass regression were similar in TAVR an

272 ialysate sodium of 135 mmol/L did not reduce left ventricular mass relative to control, despite impro

273 Left ventricular mass remained constant in all race/gend

274 nce: rs4552931 in UBE2V2 (P=1.43x10(-7)) for left ventricular mass, rs7213314 in WIPI1 (P=1.68x10(-7)

275 P =.001; patients: +8 mL [6%], P =.001) and left ventricular mass smaller (healthy subjects: -25 g (

276 nhancement extent dropped from 8.5+/-9.2% of left ventricular mass to 3.0+/-5.2% ( P=0.0001) with pre

277 sulted in a greater increase in the ratio of left ventricular mass to chamber volume and a better pre

278 positively related to the ratio of elevated left ventricular mass to end-diastolic volume (0.02 g/mL

279 , leading to a significantly higher ratio of left ventricular mass to end-diastolic volume (by 8%).

280 entric remodeling determined by the ratio of left ventricular mass to end-diastolic volume (M/V ratio

281 content is a strong explanatory variable for left ventricular mass, unaffected by BP and total body o

282 Left-ventricular mass, wall thickness; myocyte size, myo

283 The gain in left ventricular mass was 73% in heart transplant recipi

284 ynamics was measured by Pulse Wave Analysis, left ventricular mass was assessed by echocardiography,

285 After adjustment for confounders, the mean left ventricular mass was found to be 26 gm lower in pat

286 For every 1% higher glycated hemoglobin, left ventricular mass was higher by 3.0 g (95% confidenc

287 -/-)ApoB(100/100) mice with aortic stenosis, left ventricular mass was increased by 67% (P=0.001) and

288 Left ventricular mass was increased, consistent with gen

289 n (36% vs. 3%), and age- and gender-adjusted left ventricular mass was lower (90 +/- 27 g/m vs. 117 g

290 Conclusion Elevated left ventricular mass was strongly associated with hard

291 MVO extent (% left ventricular mass) was determined by cardiovascular

292 Infarct size (% of total left ventricular mass) was significantly higher in the h

293 dialysate sodium during hemodialysis reduces left ventricular mass, we conducted a randomized trial i

294 esistance was reduced and cardiac output and left ventricular mass were increased.

295 0 mL; P=0.09) without significant changes in left ventricular mass were observed.

296 Increased vascular resistance and left ventricular mass were the most consistent findings

297 Patients with extensive LGE (>=15% of left ventricular mass) were at highest risk (HR, 12; 95%

298 Regression of left ventricular mass with nocturnal hemodialysis has be

299 ng dysglycemia was associated with increased left ventricular mass, worse diastolic function, and sub

300 ntricular mass index (right ventricular mass/left ventricular mass) x 7.57 + black blood slow flow sc